Search for: "Lisa Ouellette"
Results 121 - 140
of 169
Sorted by Relevance
|
Sort by Date
3 Jun 2021, 8:56 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]
30 Oct 2020, 12:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
27 May 2020, 12:00 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
7 Apr 2020, 7:34 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowThe escalating pandemic has caused devastating shortages not only of ventilators and personal protective equipment like masks, but also of essential medicines needed to treat COVID-19 patients. [read post]
12 Oct 2020, 11:52 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsA recent STAT News report found that Operation Warp Speed—the government’s Manhattan Project-style effort to quickly develop a COVID-19 vaccine—has substantial military involvement. [read post]
22 Mar 2017, 4:42 am
” In a Wall Street Journal op-ed, Daniel Hamel and Lisa Larrimore Ouellette maintain that the case is essentially “about price discrimination, the practice of charging higher prices to customers who likely can pay more and offering discounts to those who cannot,” and they urge the justices to “consider what their decision might mean for consumers beyond the U.S. [read post]
27 Mar 2017, 4:18 am
At Written Description, Lisa Ouellette offers some “thoughts on the policy tradeoffs” at play in Impression Products, Inc. v. [read post]
9 Sep 2012, 4:24 pm
Sawicki, Assistant Professor, Loyola Chicago School of Law; 2003-2009, George Sharswood Fellow in Law and Bioethics, University of Pennsylvania Law School Lisa Comeau, Esq., appellate counsel for the patient’s family in Cronin v. [read post]
1 May 2018, 4:37 am
Lisa Ouellette has astutely observed that the importance of agency-head final decision-making authority merits further theoretical development and empirical investigation. [read post]
21 Jan 2015, 2:46 am
Commentary comes from Lisa Larrimore Ouellette at Written Description. [read post]
1 Feb 2022, 6:48 am
Durvasula, Lisa Larrimore Ouellette, and Heidi L. [read post]
6 Feb 2015, 6:00 am
Lisa Larrimore Ouellette (Stanford) (@PatentScholar) has created a Twitter list that makes it easier to follow all of the professors listed in the census. [read post]
6 Jan 2015, 6:46 pm
Thomas Anthony Niedwiecki LawProfAnt John Marshall (Chicago) Sean Nolon snolon Vermont Tracy Norton millennialprof Touro Tracy Norton profnorton Touro Beth Simone Noveck bethnoveck NYLS Rory O'Connell rjjoconnell Queens University Belfast Shuyi Oei ShuyiOei Tulane Paul Ohm paulohm Colorado David Opderbeck dopderbeck Seton Hall Lisa Ouellette PatentScholar Stanford Kevin Outterson koutterson Boston University Jessica Owley JessicaOwley Buffalo Frank Pasquale FrankPasquale Seton… [read post]
20 May 2020, 1:58 pm
Guest Post by Colleen V. [read post]
15 Apr 2020, 8:14 am
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob SherkowIt’s now clear that expansive, population-wide testing is part-and-parcel of every successful COVID-19 containment strategy. [read post]
19 May 2020, 3:30 pm
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsLast week, we focused on incentives for developing clinical evidence supporting the use of remdesivir for COVID-19 and analyzed the FDA’s grant of an emergency use authorization (EUA) for the drug. [read post]
Why is HHS blocking FDA from regulating some diagnostics, and how will this affect COVID-19 testing?
25 Aug 2020, 4:50 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
25 Mar 2021, 1:24 pm
By Lisa Larrimore Ouellette, Nicholson Price, Rachel Sachs, and Jacob S. [read post]
19 Aug 2020, 10:58 am
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsModerna, Inc., a Cambridge, MA-based biotech company, is a leading contender in the race to develop a SARS-CoV-2 vaccine. [read post]
10 Jul 2020, 8:59 am
Sherkow, Lisa Larrimore Ouellette, and Nicholson PricePolicymakers are expectantly awaiting the development of a COVID-19 vaccine, which they view as critical to future management of the pandemic. [read post]
